| HOME >> MEDICINE >> TECHNOLOGY |
Pfizer Acquires Wyeth 27
Taisho Pharmaceutical Takes Over OTC Drugs Business of
Bristol-Myers Squibb 27
Piramal Healthcare Acquires Minrad International 28
Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas 28
Abbott Acquires PG110 from PanGenetics 28
Sanofi-aventis Mexico Takes Over Laboratorios Kendrick 28
WraSer Acquires e5 Pharma's Trezix 28
Astellas Acquires Exclusive rights to Pain-Relief Drug from
Neuroges 29
Henan Lingrui Pharma Commences Construction of New Analgesic
Factory 29
Labopharm Europe Enters into Agreement with Merck Sharp & Dohme 29
Cumberland Pharmaceuticals Enters into a Commercialization
Agreement with DB Pharm Korea 29
Cumberland Pharmaceuticals Inks an Exclusive Agreement with
Phebra 30
Mallinckrodt Acquires Rights of Exalgo Extended-Release
Tablets from Neuromed 30
Labopharm Europe and Grunenthal Sign Distribution and Supply
Agreement 30
Timm Medical and Ferring Co-promote Prosed DS in the US 30
Competitive Technologies and Fintrade Medical Ink Sales and
Distribution Agreement 31
Accumetrics and Endotech Ink Exclusive Distribution Agreement 31
Astellas and NeurogesX Sign Distribution and Marketing Agreement 31
Akela Pharma Inks Agreement with Teikoku Seiyaku 31
Medical Nutrition Inks Exclusive Licensing Agreement with DSE
Healthcare 32
Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma 32
Circ Pharma Signs a Development Agreement with Elan 33
Orexo Inks Distribution Agreement with Neopharm 33
Orexo Inks Agreement with NovaMed Pharmaceuticals 33
Pharmos and Reperio Enter into Agreement 33
Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet 34
Purdue Pharma Provides Labopharm's RYZOLT 34
Bayer Acquires Sagmel's OTC Business 34
'/>"/>| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |